Clinical Report: Impact of a Mobile Health Application on Speech and Swallowing Abilities in Patients with ALS
Overview
This study evaluates the effectiveness of the 365 Healthy Swallow Health Coach app, which implements the ASSET program, in improving speech and swallowing functions in patients with ALS. The findings suggest potential benefits for dysarthria and dysphagia outcomes, addressing a significant gap in therapeutic interventions for this population.
Background
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that leads to severe impairments in speech and swallowing, significantly affecting patients' quality of life. The prevalence of ALS is notable, with approximately 4.42 cases per 100,000 individuals globally. Despite the high incidence of speech and swallowing difficulties, evidence-based therapeutic options remain limited, highlighting the need for innovative and accessible interventions.
Data Highlights
No numerical data available in the source material.
Key Findings
The ASSET program combines effortful swallow and Mendelsohn maneuver techniques to improve swallowing function.
Participants engaged with the app for 8 weeks, completing structured exercises three times a day.
Speech impairment occurs in about 25% of ALS patients as an initial symptom, with nearly 100% of bulbar-onset patients experiencing it.
Dysphagia in ALS affects all stages of swallowing and can lead to malnutrition and aspiration pneumonia.
Research on exercise-based interventions in ALS shows promise, though existing studies often lack robust methodologies.
Clinical Implications
Healthcare providers should consider integrating mobile health applications like the 365 Healthy Swallow Health Coach into treatment plans for ALS patients to enhance speech and swallowing functions. Early and proactive management of bulbar dysfunction is essential, as it can significantly improve patient outcomes and quality of life.
Conclusion
The study underscores the potential of mobile health interventions in addressing critical speech and swallowing challenges faced by ALS patients. Continued research is necessary to validate these findings and optimize therapeutic strategies.
